SiBone Q4 Earnings Call Highlights
SiBone (NASDAQ:SIBN) executives highlighted record revenue, increased physician adoption, and a shift to profitability metrics in the company’s fourth-quarter 2025 earnings call, while outlining growth initiatives tied to reimbursement tailwinds, new product launches, and an expanded commercial footprint entering 2026. Fourth-quarter and full-year results For the fourth quarter ended Dec. 31, 2025, SI-BONE reported worldwide […]
27 Feb 01:10 · The Markets Daily